TruTrace Technologies Inc

Full interview: TruTrace Technologies prepares to start Phase 2 testing of verification pilot program

TruTrace Technologies (CSE: TTT) CEO Robert Galarza joined Steve Darling from Proactive in Toronto to shares new the company, along with with their Partners at Shoppers Drug Mart, is about to begin Phase two testing of the StrainSecure platform.

Galarza talked about another company that will be a part of that. Galarza also told Proactive about their strategic alliance with Deloitte and how key that is for this growing company. 

Quick facts: TruTrace Technologies Inc

Price: $0.23

Market: CSE
Market Cap: $18.45 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of TruTrace Technologies Inc named herein, including the promotion by the Company of TruTrace Technologies Inc in any Content on the Site, the...



Buds & Duds: Cannabis stocks flat to close the week; TruTrace, Nextleaf...

Cannabis stocks were quiet on Friday as the top indices tracking the pot sector remained relatively flat. The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched 0.5% higher at 184.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index...

1 week, 2 days ago

2 min read